Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

APO-RABEPRAZOLE

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is APO-RABEPRAZOLE discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that APO-RABEPRAZOLE 10MG has been permanently discontinued (last updated September 12, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is APO-RABEPRAZOLE not available?

The reason the manufacturer reported: Business reasons.

Guide

Proton Pump Inhibitor (PPI) Shortage in Canada: Omeprazole, Pantoprazole, Rabeprazole

Why a shortage of one PPI brand rarely means the whole class is unavailable, when a pharmacist can swap manufacturers, and when it needs your prescriber.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file3 products
Affected strength10MG
Report last updated2019-09-12
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

SANDOZ RABEPRAZOLE

SANDOZ CANADA INCORPORATED

10MG · DIN 02314177

Same strengthSame dosage formSame routeNo current shortage

Other Products

PARIET, ENTERIC-COATED TABLET 20MG

JANSSEN INC

20MG · DIN 02243797

Different strengthSame dosage formSame routeNo current shortage

RABEPRAZOLE

SIVEM PHARMACEUTICALS ULC

20MG · DIN 02385457

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

DIN

02345579

Strength

10MG

Dosage Form

TABLET (ENTERIC-COATED)

Route

ORAL

Active Ingredient

RABEPRAZOLE SODIUM

See all RABEPRAZOLE SODIUM products →

Shortage History